Livongo

46 articles about Livongo

• Teladoc Health Completes Merger with LivongoCombination Creates the Global Leader in Whole-Person Virtual Care

  10/30/2020

  Teladoc Health (NYSE: TDOC), the global leader in whole person virtual care, today announced that it has completed its merger with Livongo. The milestone marks completion of the most significant blending of capabilities and talent in the history of digital health. By joining the market leaders in virtual care and applied health signals, the combined company becomes the only consumer and healthcare provider partner to span a person’s entire health

• Teladoc Health Announces Shareholder Approvals in Merger with Livongo

  10/29/2020

  Teladoc Health (TDOC), the global leader in whole person virtual care, today announced that its shareholders have overwhelmingly showed their support for the merger with Livongo (LVGO) by voting to approve the Teladoc Health charter amendment and share issuance. During Teladoc Health’s Special Meeting of shareholders held earlier today, Teladoc Health’s shareholders approved the Teladoc Health charter amendment and share issuance, with more tha

• Livongo to Release Results for the Third Quarter of Fiscal Year 2020

  10/15/2020

  Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Given the pending transaction with Teladoc Health, Livongo is not hosting a conference call in conjunction with its third quarter of 2020 earnings release. About Livongo Livongo empowers people with chronic conditions to live better and healthi

• Teladoc Health and Livongo File Definitive Proxy Statement

  9/16/2020

  Special Meetings to Be Held on October 29, 2020 Unanimously Recommend Stockholders Vote “For” the Merger and Other Proposals Set Forth in the Definitive Proxy Statement Transaction on Track to Close by End of Fourth Quarter of 2020

• Livongo to Present at Upcoming Investor Conference

  8/12/2020

  Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conference: Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13 at 8:30 a.m. Eastern Time A live webcast of

• Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Unique Diabetes Management Insights

  6/18/2020

  Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of two studies that demonstrate how remote monitoring technologies can utilize continuous and unique data insights via its AI+AI® engine to better inform care decisions and outcomes. The research findings were presented at the American Diabetes Associati

• Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior Notes Offering

  6/2/2020

  Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the pricing of $475.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities

• Livongo Expands Relationship with CVS Health, Now Part of Chronic Condition Management Platform within Point Solutions Service

  3/12/2020

  CVS Health pharmacy benefit management clients can now easily implement the Livongo for Diabetes, Hypertension, Weight Management, and Diabetes Prevention programs through an alternative contracting path

• Livongo and Dexcom Partner to Integrate Dexcom’s G6 Continuous Glucose Monitoring System into Livongo’s Applied Health Signals Platform

  1/13/2020

  Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with Diabetes

• Livongo Diabetes and Hypertension Solutions Now Available via Higi Smart Stations at Major Retailers

  1/9/2020

  Health consumers can soon access Livongo’s Applied Health Signals Platform for the Whole Person starting at prominent locations and leading pharmacy retailers in Michigan

• Livongo Earns Preferred Status on New Express Scripts Digital Health Formulary

  12/12/2019

  Participating health plans and employers can now expand access to Livongo’s leading Diabetes, Hypertension, and Weight Management solutions

• Livongo Announces Pricing of Public Offering by Selling Stockholders

  12/11/2019

  Livongo will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders, and will bear the costs associated with the sale of such shares, other than underwriting discounts and commissions.

• Livongo Announces Launch of Proposed Public Offering by Selling Stockholders

  12/9/2019

  The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed.

• Livongo Integrates Access to Telehealth in Support of People Living with Chronic Conditions

  10/28/2019

  Connects with leading telehealth companies to make it easier for Members to access virtual acute and primary care clinicians

• Livongo to Release Results for the Third Quarter of Fiscal Year 2019

  10/14/2019

  Financial results will be issued in a press release prior to the call. Livongo management will host the call, followed by a question answer session.

• CLSA Names 2019 Pantheon DiNATM Award Winners, Recognizing Advancements in California Life Sciences

  9/25/2019

  California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, has announced the 2019 Pantheon DiNATM Awards slate of honorees.

• Livongo Integrates with Leading Smartwatches; Delivers Personalized Health Insights to People with Chronic Conditions

  6/26/2019

  Livongo to Push Health Nudges to Members on Apple Watch, Fitbit, and Samsung Devices

• Study Demonstrates Livongo Members More Empowered and Less Distressed in Diabetes Self-Management

  6/10/2019

  The research findings were presented on June 8, 2019 at the American Diabetes Association's 79th Scientific Sessions held in San Francisco, California.

• Livongo Appoints Karen L. Daniel to Board of Directors to Lead Audit Committee

  6/4/2019

  Former Chief Financial Officer of Black & Veatch Brings Breadth of Financial Policy Experience to Support Livongo's Rapid Growth and Expansion

• Livongo Announces Launch of New Book, "Decoding Health Signals: Silicon Valley's Consumer-First Approach to a New Era of Health"

  5/21/2019

  Livongo announced the launch of Livongo President, Dr. Jennifer Schneider's book, "Decoding Health Signals: Silicon Valley's Consumer-First Approach to a New Era of Health," published by Lafayette American, LLC.